Novartis Investigative Site

Abu Dhabi 51900

0 studies enrolling now · 5 studies all time

What they study most

Acute Heart Failure, Heart Failure With Reduced Ejection Fraction (HF-rEF), Multiple Sclerosis, Philadelphia Chromosome-Positive Chronic Myeloid Leukemia, Relapsing Multiple Sclerosis

Studies at this site

• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) — Running, not enrolling
• The Gilenya Pregnancy Registry — Completed
• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE
• Global Non-interventional Heart Failure Disease Registry — Stopped early